Kidney Disease

Chinook Therapeutics Raises $105 Million for Kidney Disease Therapies

Edward Kim | |

The company is in Phase 3 trials with atrasentan for IgA nephropathy (IgAN).

Regulus Therapeutics — Microcap Play in Targeted MicroRNA Medicines

Edward Kim | |

The stock is trading below its cash value.

Ardelyx Secures $27.5 Million Debt Financing From SLR Capital

Edward Kim | |

The funds come at a critical time for the embattled biotech.

Vera Therapeutics Raises $72 Million in Follow-on Equity Offering

Edward Kim | |

The company is developing treatments to change the standard of care for patients with immunologic diseases, with initial targets in severe kidney diseases.

Sponsored Financial Content

Market Movers